Quick Answer
Passage BIO, Inc. reported Total Assets of $62.28 million for fiscal year 2025.
Passage BIO, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $62.28M | -39.2% |
| 2024 | $102.41M | -32.0% |
| 2023 | $150.54M | -38.2% |
| 2022 | $243.55M | -31.4% |
| 2021 | $355.08M | +8.3% |
| 2020 | $328.01M | +83.6% |
| 2019 | $178.61M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $74.16M | -33.6% | -6.4% |
| June 30, 2025 | $79.20M | -36.8% | -7.9% |
| March 31, 2025 | $86.01M | -38.8% | -16.0% |
| December 31, 2024 | $102.41M | -32.0% | -8.4% |
| September 30, 2024 | $111.75M | -34.0% | -10.9% |
| June 30, 2024 | $125.39M | -35.3% | -10.8% |
| March 31, 2024 | $140.53M | -34.1% | -6.7% |
| December 31, 2023 | $150.54M | -38.2% | -11.1% |
- Passage BIO, Inc. showed a decrease of -39.2% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Passage BIO, Inc.’s total assets has declined by 65.1% (from $178.61 million to $62.28 million).
- The most recent figure is from Passage BIO, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: